Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Aspira Women's Health Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2024
- Shares held
- 1.40M
- −496.7K (−26.2%) vs. Q1 2024
- Total value
- $2.08M
- −$4.07M (−66.2%) vs. Q1 2024
- New holders
- 5
- 9 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 468,000 | $697.3K | 0.02% | −689,000−59.6% | Reduced |
| Vanguard Group Inc | 277,407 | $413.3K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 236,396 | $352.2K | 0.01% | +111,022+88.6% | Added |
| BlackRock Inc. | 73,380 | $109.3K | 0.00% | +10,614+16.9% | Added |
| Geode Capital Management, LLC | 72,892 | $108.6K | 0.00% | +13,348+22.4% | Added |
| Quantum Private Wealth, LLC | 53,418 | $79.6K | 0.03% | +1,000+1.9% | Added |
| Northern Trust Corp | 33,015 | $49.2K | 0.00% | −320−1.0% | Reduced |
| Bank of America Corp | 29,346 | $43.7K | 0.00% | −80.0% | Reduced |
| Northeast Financial Consultants Inc | 23,436 | $34.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,749 | $29.4K | 0.00% | +1,500+8.2% | Added |
| The PNC Financial Services Group, Inc. | 15,000 | $22.4K | 0.00% | +15,000 | New |
| M&T Bank Corp | 14,999 | $22.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,492 | $20.1K | 0.00% | +13,492 | New |
| Squarepoint Ops LLC | 12,328 | $18.4K | 0.00% | −13,110−51.5% | Reduced |
| Citadel Advisors LLC | 11,754 | $17.5K | 0.00% | +11,754 | New |
| XTX Topco Ltd | 11,032 | $16.4K | 0.00% | +11,032 | New |
| HRT Financial LP | 10,903 | $16.0K | 0.00% | +10,903 | New |
| Tower Research Capital LLC (TRC) | 6,669 | $9.94K | 0.00% | +3,223+93.5% | Added |
| Morgan Stanley | 2,422 | $3.61K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,305 | $3.43K | 0.00% | +1,399+154.4% | Added |
| JPMorgan Chase & Co | 2,079 | $3.10K | 0.00% | +2+0.1% | Added |
| Royal Bank of Canada | 2,348 | $3.00K | 0.00% | +2,206+1,553.5% | Added |
| Castleview Partners, LLC | 1,316 | $1.96K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,049 | $1.56K | 0.00% | 00.0% | Unchanged |
| Operose Advisors LLC | 1,000 | $1.49K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 119 | $177 | 0.00% | 00.0% | Unchanged |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −51−100.0% | Sold out |